ASX Share rice
Mon 17 May 2021 - 03:15:am (Sydney)

AFP Share Price

AFT PHARMACEUTICALS LIMITEDAFPPharmaceuticals, Biotechnology & Life Sciences

AFP Company Information

Name:

AFT Pharmaceuticals Limited

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

Address:

129 Hurstmere Road Auckland New Zealand 0622

Phone:

64 9 488 0232

Full Time Employees:

86

Founder, CEO, MD & Exec. Director:

Dr. Hartley Atkinson

Chief of Staff & Exec. Director:

Ms. Marree Atkinson

CFO & Company Sec.:

Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ

Group Marketing Mang.:

Mr. Murray Keith

Head of Drug Devel.:

Ms. Ioana Stanescu

Gen. Mang. of AFT Australia:

Mr. Calvin Mackenzie

Gen. Mang. of Promoted Products Australasia & South East Asia:

Mr. Scott Crawford

Director of International Bus.:

Ms. Louise Clayton

Company Overview:

AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

AFP Share Price Information

Shares Issued:

104.58M

Market Capitalisation:

$439.25M

Revenue (TTM):

$107.47M

Revenue Per Share (TTM):

$1

Earnings per Share:

$0.026

Profit Margin:

0.037

Operating Margin (TTM):

$0.11

Return On Assets (TTM):

$0.08

Return On Equity (TTM):

$0.18

Quarterly Revenue Growth (YOY):

0.04

Gross Profit(TTM):

$48.27M

Diluted Earnings Per Share (TTM):

$0.026

QuarterlyEarnings Growth(YOY):

-0.9

AFP CashFlow Statement

CashFlow Date:

2020-03-31

Investments:

$-6,562,000

Change To Liabilities:

$5.88M

Total Cashflow From Investing Activities:

$-6,562,000

Net Borrowings:

$-2,655,000

Net Income:

$12.69M

Total Cash From Operating Activities:

$14.88M

Depreciation:

$0.96M

Dividends Paid:

$-566,000

Change To Inventory:

$2.43M

Change To Account Receivables:

$-7,297,000

Sale Purchase Of Stock:

$3K

Capital Expenditures:

$92K

AFP Income Statement

Income Date:

2020-03-31

Income Before Tax:

$12.88M

Net Income:

$12.69M

Gross Profit:

$48.27M

Operating Income:

$21.21M

Other Operating Expenses:

$-535,000

Interest Expense:

$80K

Income Tax Expense:

$185K

Total Revenue:

$105.60M

Cost Of Revenue:

$57.33M

AFP Balance Sheet

Balance Sheet Date:

2020-03-31

Intangible Assets:

$26.98M

Total Liabilities:

$69.80M

Total Stockholder Equity:

$17.26M

Other Current Liabilities:

$7.39M

Total Assets:

$87.05M

Common Stock:

$57.06M

Other Current Assets:

$514K

Retained Earnings:

$-49,275,000

Other Assets:

$12.23M

Cash:

$6.12M

Total Current Liabilities:

$25.10M

Property - Plant & Equipment:

$4.03M

Net Tangible Assets:

$-9,000,000

Total Current Assets:

$55.34M

Long-Term Debt:

$41.20M

Net Receivables:

$22.63M

Short-Term Investments:

$31.72M

Inventory:

$22.73M

Accounts Payable:

$8.62M

Non Currrent Assets (Other):

$31.72M

Short-Term Investments:

$31.72

Non Current Liabilities Total:

$44.70M

AFP Share Price History

AFP News

20 Apr, 2021
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
20 Jan, 2021
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
21 Nov, 2020
AFT Pharmaceuticals Limited (NZSE:AFT) missed earnings with its latest half-year results, disappointing...
08 Nov, 2020
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
24 Sep, 2020
How far off is AFT Pharmaceuticals Limited (NZSE:AFT) from its intrinsic value? Using the most recent financial data...
18 Aug, 2020
Hartley Atkinson has been the CEO of AFT Pharmaceuticals Limited (NZSE:AFT) since 1997, and this article will examine...
13 Jul, 2020
The big shareholder groups in AFT Pharmaceuticals Limited (NZSE:AFT) have power over the company. Institutions often...
24 May, 2020
AFT Pharmaceuticals Limited (NZSE:AFT) defied analyst predictions to release its full-year results, which were ahead...